No abstract available
MeSH terms
-
Adalimumab
-
Adult
-
Aged
-
Aged, 80 and over
-
Anaphylaxis / diagnosis
-
Anaphylaxis / drug therapy
-
Anaphylaxis / etiology
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized / adverse effects*
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Autoimmune Diseases / drug therapy*
-
Drug Hypersensitivity / diagnosis
-
Drug Hypersensitivity / drug therapy
-
Drug Hypersensitivity / etiology*
-
Etanercept
-
Female
-
Humans
-
Immunoglobulin E / immunology
-
Immunoglobulin G / adverse effects*
-
Immunoglobulin G / therapeutic use
-
Infliximab
-
Italy
-
Male
-
Middle Aged
-
Receptors, Tumor Necrosis Factor / therapeutic use
-
Treatment Failure
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
-
Urticaria / diagnosis
-
Urticaria / drug therapy
-
Urticaria / etiology
-
Young Adult
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Immunoglobulin G
-
Receptors, Tumor Necrosis Factor
-
Tumor Necrosis Factor-alpha
-
Immunoglobulin E
-
Infliximab
-
Adalimumab
-
Etanercept